SCHEMBL19981582

SCHEMBL19981582

CC(C)(C)CN1CC(C)(OCCN2CCC(F)(F)C2)C1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.34
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10160074 0.78 RORC (0.33)
SCHEMBL22349071 0.73 ALDH1A1 (0.33) DRD2
SCHEMBL9944465 0.71 KCNH2 (0.38)
SCHEMBL12712697 0.71 CNR2 (0.37) DRD2HTR2AHTR2C
SCHEMBL9924111 0.70 NOS3 (0.31)
SCHEMBL9911490 0.70 SLC6A4 (0.31)
SCHEMBL9924119 0.70 KCNQ3 (0.30)
SCHEMBL24914244 0.68 HRH3 (0.35)
SCHEMBL12872465 0.68 HRH3 (0.33) HTR2AHTR2C
SCHEMBL13600627 0.68 HRH3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed